Can-Fite BioPharma Ltd.CANFNYSE
Loading
ROE: Returns DecliningContracting
Percentile Rank57
Year-over-Year Change
Return on equity
Latest
-144.96%
↑ 25% vs avg
Percentile
P57
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-194.27%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -144.96% | -18.5% |
| 2023 | -122.28% | +46.2% |
| 2022 | -227.48% | -159.8% |
| 2021 | -87.57% | +63.2% |
| 2020 | -237.78% | +54.0% |
| 2019 | -516.99% | -137.2% |
| 2018 | -217.94% | -34.0% |
| 2017 | -162.70% | +8.8% |
| 2016 | -178.44% | -283.7% |
| 2015 | -46.50% | - |